First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi

Journal of Epidemiology and Global Health

Volumn 5, Issue 4, 2015, Pages 365-373

  Myneedu, Vithal Prasad ^a   Singhal, Ritu ^a   Khayyam, Khalid Umer ^a   Sharma, Prem Prakash ^a   Bhalla, Manpreet ^a   Behera, Digamber ^b   Sarin, Rohit ^a  

^a NATIONAL INSTITUTE OF TUBERCULOSIS AND RESPIRATORY DISEASES   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antibiotic; Extensively drug resistance; Multi drug resistance; Primary; Pulmonary

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE REGISTRY; DISEASE SURVEILLANCE; DRUG RESISTANCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; FIRST LINE DRUG RESISTANCE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SECOND LINE DRUG RESISTANCE; SEX RATIO; SHORT COURSE THERAPY; SMOKING; SPUTUM SMEAR; SYMPTOM; TUBERCULOSIS CONTROL; YOUNG ADULT; CHILD; DRUG EFFECTS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; MICROBIOLOGY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHILD; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84946498003     PISSN: 22106006     EISSN: 22106014     Source Type: Journal    
DOI: 10.1016/j.jegh.2015.04.002     Document Type: Article

References (25)

1. Dooley S.W., Jarvis W.R., Martone W.J., Snider D. Multidrug-resistant tuberculosis. Ann Intern Med 1992, 117:257-259.
2. World Health Organization. Global Tuberculosis Report, Geneva, Switzerland, WHO Report 2013 WHO/HTM/TB Geneva, Switzerland, 2013.
3. Shah N.S., Wright A., Bai G.H., Barerra L., Boulahbal F. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2014, 13:30-37.
4. McGrath M., Pittius Gey van N.C., Van Helden P.D., Warren R.M., Warner D.F. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2014, 69:292-302.
5. Sharma S.K., Kaushik G., Jha B. Prevalence of multi-drug resistant tuberculosis among newly diagnosed cases of sputum positive pulmonary tuberculosis. Indian J Med Res 2011, 133:308-311.
6. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis: WHO Report 2009 WHO/HTM/TB Geneva, Switzerland, 2009.
7. Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Revised National Tuberculosis Control Programme, Module for laboratory technicians: RNTCP 2005, New Delhi, India.
8. Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Revised National Tuberculosis Control Programme, Manual of standard operating procedures of culture of Mycobacterium tuberculosis and drug susceptibility testing on solid medium: RNTCP 2009, New Delhi, India.
9. Shao Y., Yang D., Xu W., Lu W., Song H. Epidemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead. BMC Public Health 2011, 11:110.
10. Alcaide J., Altet M.N., Plans P., Parrón I., Folguera L. Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study. Tuber Lung Dis 1996, 77:112-116.
11. Anamika G., Jitendra P.M., Surya K.S., Anil K.G., Shampa A. Antitubercular drug resistance in four healthcare facilities in North India. J Health Popul Nutr 2011, 29:583-592.
12. Chang S.W., Pan W.S., Beltran D.L., Baldelomar L.O., Solano M.A., Friedland J.S., et al. Gut harmones, appetite suppression and cachexia in patients with pulmonary TB. PLoS One 2013, 8:545-564.
13. Mistry N.F., Vira T.S., Dholakia Y., Hoffner S., Pasvo G. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 2009, 211:1-9.
14. Joseph M.R., Shoby C.T., Amma G.R., Chauhan L.S., Paramasivan C.N. Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis 2007, 11:439-443.
15. Ramachandran R., Nalini S., Chandrasekar V., Dave P.V., Sanghvi A.S., Wares F. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009, 13:1154-1160.
16. Paramasivan C.N., Venkataraman P., Chandrasekaran V., Bhat S., Narayanan P.R. Surveillance of drug resistance in tuberculosis in two districts of south India. Int J Tuberc Lung Dis 2002, 6:479-484.
17. Jain A., Mondal R., Prasad R., Singh K., Ahuja R.C. Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian J Med Res 2008, 128:300-306.
18. Jain N.K., Chopra K.K., Prasad G. Initial and acquired isoniazid and rifampicin resistance to Mycobacterium tuberculosis and its implication for treatment. Indian J Tuberc 1992, 39:12-14.
19. Zwerling A., White R.G., Vassall A., Cohen T., Dowdy D.W., Houben R.M. Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations. PLoS One 2014, 9(10):e110558.
20. Myneedu V.P., Visalakshi P., Verma A.K., Behera D., Bhalla M. Prevalence of XDR TB cases - a retrospective study from a tertiary care TB hospital. Indian J Tuberc 2011, 58:54-59.
21. Chakraborty N., De C., Bhattacharyya S., Mukherjee A., Santra S., Banerjee D., et al. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India. Trans R Soc Trop Med Hyg 2010, 104:101-195.
22. Thomas A., Ramachandaran R., Rehaman F., Jaggarajamma K., Santha T., Selvakumar N., et al. Management of multi-drug resistance tuberculosis in the field: tuberculosis Research Centre experience. Indian J Tuberc 2007, 54:117-124.
23. Mondal R., Jain A. Extensively drug resistant Mycobacterium tuberculosis, India. Emerg Infect Dis 2007, 13:1429-1431.
24. Michael J.S., John T.J. Extensively drug-resistant tuberculosis in India: a review. Indian J Med Res 2012, 1(36):504-599.
25. Horsburg J. Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons. J Infect Dis 2008, 198:1577-1578.